These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28468594)

  • 1. Prostate-derived Ets factor, an oncogenic driver in breast cancer.
    Sood AK; Geradts J; Young J
    Tumour Biol; 2017 May; 39(5):1010428317691688. PubMed ID: 28468594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDEF in prostate cancer.
    Sood AK; Kim H; Geradts J
    Prostate; 2012 May; 72(6):592-6. PubMed ID: 21796651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signatures of prostate-derived Ets factor (PDEF) in cancer.
    Mahajan N
    Tumour Biol; 2016 Nov; 37(11):14335-14340. PubMed ID: 27612480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.
    Sood AK; Saxena R; Groth J; Desouki MM; Cheewakriangkrai C; Rodabaugh KJ; Kasyapa CS; Geradts J
    Hum Pathol; 2007 Nov; 38(11):1628-38. PubMed ID: 17521701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancer.
    Turcotte S; Forget MA; Beauseigle D; Nassif E; Lapointe R
    Neoplasia; 2007 Oct; 9(10):788-96. PubMed ID: 17971898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of PDEF factor expression and its relation to androgen receptor in ER
    Cao L; Li C; Xu C; Xiang G; Liu F; Liu X; Jiao J; Lv S; Niu Y
    Histopathology; 2018 Nov; 73(5):819-831. PubMed ID: 29969155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
    Steffan JJ; Koul HK
    Cancer Lett; 2011 Nov; 310(1):109-17. PubMed ID: 21764212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic modifications of prostate-derived Ets transcription factor in breast cancer cells.
    Sabherwal Y; Mahajan N; Zhang M
    Oncol Rep; 2013 Oct; 30(4):1985-8. PubMed ID: 23921628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis.
    Sood AK; Wang J; Mhawech-Fauceglia P; Jana B; Liang P; Geradts J
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1899-903. PubMed ID: 19505923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDEF downregulates stathmin expression in prostate cancer.
    Sabherwal Y; Mahajan N; Helseth DL; Gassmann M; Shi H; Zhang M
    Int J Oncol; 2012 Jun; 40(6):1889-99. PubMed ID: 22378487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
    Ghadersohi A; Sood AK
    Clin Cancer Res; 2001 Sep; 7(9):2731-8. PubMed ID: 11555586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer.
    Findlay VJ; Turner DP; Moussa O; Watson DK
    Cancer Res; 2008 Oct; 68(20):8499-506. PubMed ID: 18922924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.
    Ghadersohi A; Pan D; Fayazi Z; Hicks DG; Winston JS; Li F
    Breast Cancer Res Treat; 2007 Mar; 102(1):19-30. PubMed ID: 16897429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer.
    Ghadersohi A; Sharma S; Zhang S; Azrak RG; Wilding GE; Manjili MH; Li F
    Prostate; 2011 Aug; 71(11):1178-88. PubMed ID: 21656828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex.
    Cho JY; Lee M; Ahn JM; Park ES; Cho JH; Lee SJ; Kim BG; Heo SH; Park HJ; Zerbini LF; Hwang D; Libermann TA
    J Proteome Res; 2009 Mar; 8(3):1327-37. PubMed ID: 19203193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel role for PDEF in epithelial cell migration and invasion.
    Gunawardane RN; Sgroi DC; Wrobel CN; Koh E; Daley GQ; Brugge JS
    Cancer Res; 2005 Dec; 65(24):11572-80. PubMed ID: 16357167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
    Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
    Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer.
    Turner DP; Moussa O; Sauane M; Fisher PB; Watson DK
    Cancer Res; 2007 Feb; 67(4):1618-25. PubMed ID: 17308102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells.
    Wang F; Koul S; Shanmugam PST; Dong Q; Koul HK
    Mol Cancer Res; 2018 Sep; 16(9):1430-1440. PubMed ID: 29848555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.
    Mukhopadhyay A; Khoury T; Stein L; Shrikant P; Sood AK
    Oncotarget; 2013 Apr; 4(4):610-21. PubMed ID: 23592399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.